2-Microglobulin Maintains Glioblastoma Stem Cells and Induces M2-like Polarization of Tumor-Associated Macrophages
Daqi Li,Qian Zhang,Lu Li,Kexin Chen,Junlei Yang,Deobrat Dixit,Ryan C. Gimple,Shusheng Ci,Chenfei Lu,Lang Hu,Jiancheng Gao,Danyang Shan,Yangqing Li,Junxia Zhang,Zhumei Shi,Danling Gu,Wei Yuan,Qiulian Wu,Kailin Yang,Linjie Zhao,Zhixin Qiu,Deguang Lv,Wei Gao,Hui Yang,Fan Lin,Qianghu Wang,Jianghong Man,Chaojun Li,Weiwei Tao,Sameer Agnihotri,Xu Qian,Yu Shi,Yongping You,Nu Zhang,Jeremy N. Rich,Xiuxing Wang
DOI: https://doi.org/10.1158/0008-5472.CAN-22-0507
IF: 11.2
2022-01-01
Cancer Research
Abstract:Glioblastoma (GBM) is a complex ecosystem that includes a heterogeneous tumor population and the tumor-immune microenvironment (TIME), prominently containing tumor-associated macrophages (TAM) and microglia. Here, we demonstrated that beta 2-microglobulin (B2M), a subunit of the class I major histocompatibility complex (MHC-I), promotes the maintenance of stem-like neoplastic populations and reprograms the TIME to an anti-inflammatory, tumor-promoting state. B2M activated PI3K/AKT/m TOR signaling by interacting with PIP5K1A in GBM stem cells (GSC) and promoting MYC-induced secretion of transforming growth factor-beta 1 (TGF beta 1). Inhibition of B2M attenuated GSC survival, self-renewal, and tumor growth. B2M-induced TGF beta 1 secretion activated paracrine SMAD and PI3K/AKT signaling in TAMs and promoted an M2-like macrophage phenotype. These findings reveal tumor-promoting functions of B2M and suggest that targeting B2M or its downstream axis may provide an effective approach for treating GBM. Significance: beta 2-microglobulin signaling in glioblastoma cells activates a PI3K/AKT/MYC/TGF beta 1 axis that maintains stem cells and induces M2-like macrophage polarization, highlighting potential therapeutic strategies for targeting tumor cells and the immunosuppressive microenvironment in glioblastoma.